1-20 of 27
nonsecretory myeloma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence and Outcomes of Extramedullary Myeloma in a South Australian Hospital

Angelina Yong, BSc,BMBS, FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5504.
https://doi.org/10.1182/blood-2019-129754
Published: 2019
Journal Articles

Survival Outcomes of Young Multiple Myeloma Patients: A Single Center Experience

Pelin Aytan, MD, Mahmut Yeral, MD, Cigdem Gereklioglu, MD, Aslı Korur, MD, Funda Tanrıkulu, MD, Soner Solmaz, MD, Nurhilal Buyukkurt, MD, Mutlu Kasar, MD, Suheyl Asma, MD, Can Boga, MD, Ilknur Kozanoglu, MD, Hakan Ozdogu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5766.
https://doi.org/10.1182/blood-2018-99-118516
Published: 2018
Journal Articles

PET/CT Evaluation As a Prognostic Indicator In Relapsed Or Refractory Multiple Myeloma

Adriana C Rossi, MD, Tomer M Mark, MD, MSc, Kevin Wood, MD, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Stanley Goldsmith, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2013) 122 (21): 1878.
https://doi.org/10.1182/blood.V122.21.1878.1878
Published: 2013
Journal Articles

Is Daily Lenograstim From Day +7 Of Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Is As Effective As Pegfilgrastim In Patients With Myeloma?

Ben Bailiff, Neil Phillips, Vidhya Murthy, Lynn Bratby, Kathy Holder, Bhuvan Kishore, E Nikolousis, R Lovell, Guy Pratt, Joanne Ewing, Shankaranarayana Paneesha
Journal: Blood
Blood (2013) 122 (21): 5538.
https://doi.org/10.1182/blood.V122.21.5538.5538
Published: 2013
Journal Articles

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, Jakub Debski, MD, Aleksandra K. Butrym, MD, PhD, Wojciech Legiec, Marek Hus, MD, PhD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan M Zaucha, Marcin Rymko, MD, Tigran Torosian, MD, Grzegorz Charlinski, Ewa Lech-Maranda, Artur J. Jurczyszyn, MD, PhD, Halina Urbanska-Rys, Agnieszka Druzd-Sitek, PhD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2013) 122 (21): 3236.
https://doi.org/10.1182/blood.V122.21.3236.3236
Published: 2013
Journal Articles

Observations On Eosinophil Ifiltrates in The Bone Marrow Of Patients With Multiple Myeloma. Clinicopathological Correlates

Finella MC Brito-Babapulle, FRCPATH, Tanya Cranfield, MD, FRCP, Robert B Corser, FRCPath, Helen Dignum, Christopher James, FRCPAth, Mary Ganczakowski, FRCPath
Journal: Blood
Blood (2013) 122 (21): 5338.
https://doi.org/10.1182/blood.V122.21.5338.5338
Published: 2013
Journal Articles

Conversion of Non-Secretory to Hyper-Secretory Myeloma: The Antithesis of the Common Pathway of Dedifferentiation with Myeloma Progression: A Case Study

Shebli Atrash, MD, Al-Ola Abdallah, MD, Joshua Epstein, DSc, Christoph Heuck, MD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 5052.
https://doi.org/10.1182/blood.V120.21.5052.5052
Published: 2012
Journal Articles

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, MD, Jakub Debski, MD, Aleksandra Butrym, MD, Wojciech Legiec, MD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan Maciej Zaucha, MD, Marcin Rymko, MD, Tigran Torosian, MD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2011) 118 (21): 5125.
https://doi.org/10.1182/blood.V118.21.5125.5125
Published: 2011
Journal Articles

Assessment of the Performance of Serum Heavy Chains Immunoassay to Monitor Response to Treatment and Its Correlation with Other Tumor Measurements In Serial Samples From Patients with Newly Diagnosed MM

Attaya Suvannasankha, MD, Sherif Farag, MD, PhD, FRACP, FRCPA, Stephen Harding, PhD, Brian GM Durie, MD, Rafat Abonour, MD
Journal: Blood
Blood (2010) 116 (21): 2986.
https://doi.org/10.1182/blood.V116.21.2986.2986
Published: 2010
Journal Articles

Myelomatous Pleural Effusion of Multiple Myeloma: Characteristics and Outcome.

Hyo Jung Kim, M.D., Ph.D., Dae Ro Choi, M.D., Gak-Won Yun, M.D., Eunkyung Park, M.D., Ph.D., Seok Jin Kim, MD, PhD, Young Kyung Lee, M.D., Ph.D., Jong-Ho Won, M.D., Ph.D., Sung-Soo Yoon, M.D., Ph.D., Cheolwon Suh, M.D., Ph.D., Korean Multiple Myeloma Working Party, (KMMWP)
Journal: Blood
Blood (2009) 114 (22): 3874.
https://doi.org/10.1182/blood.V114.22.3874.3874
Published: 2009
Journal Articles

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Incidence and Characteristics in Korean Patients.

Hyo Jung Kim, M.D., Ph.D., Hyeok Shim, M.D., Eunkyung Park, M.D., Ph.D., Min Kyoung Kim, M.D., Seok Jin Kim, MD, PhD, Joon Seong Park, M.D., Ph.D., Jong-Ho Won, M.D., Ph.D., Chang-Ki Min, M.D., Ph.D., Jae Hoon Lee, M.D., Ph.D., Korean Multiple Myeloma Working Party, (KMMWP)
Journal: Blood
Blood (2009) 114 (22): 4956.
https://doi.org/10.1182/blood.V114.22.4956.4956
Published: 2009
Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Kihyun Kim, Seok Jin Kim, MD, PhD, Byung Soo Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Hye Jin Kang, MD, Jin Seok Kim, M.D., Ph.D., Yeung-Chul Mun, Chul Soo Kim, MD, Sang Kyun Sohn, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, Hyeok Shim, Hwi-Joong Yoon, Jong-Youl Jin, Chang-Ki Min, MD, Ho Jin Shin, Hyun Chun Shin, Jong-Ho Won, Je-Jung Lee, MD, PhD, Jung Hye Kwon, Young-Don Joo, MD, PhD, Young Rok Do, M.D., Sung Hyun Kim, Sukjoong Oh, MD, Cheolwon Suh, MD, Junglim Lee, Sung-Soo Yoon, Min Kyoung Kim, Soo-Mee Bang, Hun-Mo Ryoo, Bong-Seog Kim, Hawk Kim, MD, Hyo-Jung Kim, Yang Soo Kim, Chong Won Park, Gyeong-Won Lee, Seongkyu Park, Joon Seong Park, MD, Ho Young Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2009) 114 (22): 4881.
https://doi.org/10.1182/blood.V114.22.4881.4881
Published: 2009
Journal Articles

A monoclonal gammopathy precedes multiple myeloma in most patients

Clinical Trials & Observations
Brendan M. Weiss, Jude Abadie, Pramvir Verma, Robin S. Howard, W. Michael Kuehl
Journal: Blood
Blood (2009) 113 (22): 5418–5422.
https://doi.org/10.1182/blood-2008-12-195008
Published: 2009
Journal Articles

Updated Results of a Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation with Velcade ™ Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma

Mickey Liao, MD, R Malone, K Bartoni, B Habtemariam, Ronald Paquette, Sven de Vos, Mary C Territo, Gary Schiller
Journal: Blood
Blood (2008) 112 (11): 3710.
https://doi.org/10.1182/blood.V112.11.3710.3710
Published: 2008
Journal Articles

Phase I/II Trial of Bortezomib Maintenance in Order To Prolong Remission-Duration Following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma.

Gary J. Schiller, MD, M. Liao, M.D., J.P. Sohn, M.D., R. Malone, R.N., K. Bartone, R.N., B. Habtemariam, R. Paquette, M.D., S. de Vos, M.D., M. Territo, M.D.
Journal: Blood
Blood (2007) 110 (11): 3617.
https://doi.org/10.1182/blood.V110.11.3617.3617
Published: 2007
Journal Articles

Comparable Outcomes in Secretory (SM) Versus Non-Secretory (NSM) Multiple Myeloma (MM) with Autologous Hematopoietic Stem Cell Transplantation (AuHCT).

Shaji Kumar, MD, Waleska S. Pérez, MPH, Mei-Jie Zhang, PhD, Christopher N. Bredeson, MD, MSc, Martha Q. Lacy, MD, Gustavo Milone, MD, Donna Reece, MD, David H. Vesole, MD, PhD, Parameswaran Hari, MD
Journal: Blood
Blood (2007) 110 (11): 944.
https://doi.org/10.1182/blood.V110.11.944.944
Published: 2007
Journal Articles

Early Reduction of Serum Free Light Chain Can Predict Therapeutic Responses in Multiple Myeloma.

Thanyaphong Na Nakorn, MD, PhD, Phandee Watanaboonyongcharoen, MD., Seksan Suwannabutra, B.Sc.(MT), Sunee Theerasaksilp, B.Sc.(MT), Nara Paritpokee, M.Sc.
Journal: Blood
Blood (2007) 110 (11): 4742.
https://doi.org/10.1182/blood.V110.11.4742.4742
Published: 2007
Journal Articles

High-Dose Therapy Followed by Autologous HSCT in Patients with Multiple Myeloma. Results of a Retrospective Multicenter Analysis Conducted by The Polish Myeloma Group.

Wanda M. Knopinska-Posluszny, MD, PhD, Andrzej Hellmann, Michal Taszner, MD, Anna Dmoszynska, Wiktor Jedrzejczak, Jerzy Holowiecki, Jan Walewski, Krzysztof Warzocha, Aleksander Skotnicki, Andrzej Lange, Kazimierz Kuliczkowski, Kazimierz Sulek, M. Komarnicki, Tadeusz Robak
Journal: Blood
Blood (2007) 110 (11): 5108.
https://doi.org/10.1182/blood.V110.11.5108.5108
Published: 2007
Journal Articles

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

Clinical Trials & Observations
Frits van Rhee, Vanessa Bolejack, Klaus Hollmig, Mauricio Pineda-Roman, Elias Anaissie, Joshua Epstein, John D. Shaughnessy, Jr, Maurizio Zangari, Guido Tricot, Abid Mohiuddin, Yazan Alsayed, Gail Woods, John Crowley, Bart Barlogie
Journal: Blood
Blood (2007) 110 (3): 827–832.
https://doi.org/10.1182/blood-2007-01-067728
Published: 2007
Journal Articles

Complete Remission Represents the Major Surrogate Marker of Long Survival in Multiple Myeloma.

Michael Wang, MD, Kay Delasalle, Sheeba Thomas, MD, Sergio Giralt, MD, Raymond Alexanian, MD
Journal: Blood
Blood (2006) 108 (11): 403.
https://doi.org/10.1182/blood.V108.11.403.403
Published: 2006